Palogic Value Management L.P. Boosts Stock Position in Aspen Aerogels, Inc. $ASPN

Palogic Value Management L.P. boosted its holdings in shares of Aspen Aerogels, Inc. (NYSE:ASPN) by 43.5% in the second quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The firm owned 610,000 shares of the construction company’s stock after acquiring an additional 185,000 shares during the quarter. Aspen Aerogels accounts for 1.5% of Palogic Value Management L.P.’s portfolio, making the stock its 16th biggest holding. Palogic Value Management L.P.’s holdings in Aspen Aerogels were worth $3,611,000 as of its most recent SEC filing.

A number of other hedge funds and other institutional investors have also made changes to their positions in the company. Vanguard Group Inc. increased its stake in shares of Aspen Aerogels by 0.3% during the first quarter. Vanguard Group Inc. now owns 4,373,159 shares of the construction company’s stock valued at $27,944,000 after buying an additional 12,913 shares during the period. Needham Investment Management LLC grew its holdings in Aspen Aerogels by 14.5% during the 1st quarter. Needham Investment Management LLC now owns 2,737,200 shares of the construction company’s stock worth $17,491,000 after acquiring an additional 347,500 shares in the last quarter. AWM Investment Company Inc. grew its holdings in Aspen Aerogels by 102.6% during the 1st quarter. AWM Investment Company Inc. now owns 2,449,221 shares of the construction company’s stock worth $15,651,000 after acquiring an additional 1,240,535 shares in the last quarter. Gagnon Securities LLC bought a new position in Aspen Aerogels during the 2nd quarter worth about $11,243,000. Finally, Goldman Sachs Group Inc. grew its holdings in Aspen Aerogels by 89.7% during the 1st quarter. Goldman Sachs Group Inc. now owns 1,274,356 shares of the construction company’s stock worth $8,143,000 after acquiring an additional 602,586 shares in the last quarter. Institutional investors own 97.64% of the company’s stock.

Insider Buying and Selling at Aspen Aerogels

In related news, CAO Santhosh P. Daniel sold 4,410 shares of the company’s stock in a transaction on Tuesday, August 12th. The stock was sold at an average price of $7.31, for a total transaction of $32,237.10. Following the completion of the sale, the chief accounting officer directly owned 19,879 shares in the company, valued at $145,315.49. This represents a 18.16% decrease in their position. The sale was disclosed in a document filed with the SEC, which is available through this link. 4.30% of the stock is owned by company insiders.

Analyst Upgrades and Downgrades

Several brokerages have issued reports on ASPN. Barclays cut shares of Aspen Aerogels from an “equal weight” rating to an “underweight” rating and increased their target price for the stock from $7.00 to $16.00 in a report on Monday, August 11th. Weiss Ratings reiterated a “sell (d)” rating on shares of Aspen Aerogels in a report on Wednesday, October 8th. Finally, Canaccord Genuity Group dropped their target price on shares of Aspen Aerogels from $11.00 to $10.00 and set a “buy” rating on the stock in a report on Friday, August 8th. One analyst has rated the stock with a Strong Buy rating, four have given a Buy rating, two have given a Hold rating and two have given a Sell rating to the company’s stock. According to MarketBeat, the company has an average rating of “Hold” and an average target price of $15.50.

Aspen Aerogels Trading Up 8.4%

Shares of NYSE ASPN opened at $8.17 on Friday. The company has a debt-to-equity ratio of 0.34, a current ratio of 3.98 and a quick ratio of 3.31. The stock has a market capitalization of $672.55 million, a P/E ratio of -2.14 and a beta of 2.80. Aspen Aerogels, Inc. has a 1-year low of $4.16 and a 1-year high of $18.95. The business has a fifty day moving average price of $7.39 and a 200 day moving average price of $6.74.

Aspen Aerogels (NYSE:ASPN) last issued its quarterly earnings data on Thursday, August 7th. The construction company reported ($0.04) earnings per share for the quarter, topping analysts’ consensus estimates of ($0.12) by $0.08. The firm had revenue of $78.02 million during the quarter, compared to analysts’ expectations of $72.53 million. Aspen Aerogels had a positive return on equity of 2.92% and a negative net margin of 78.53%.The firm’s quarterly revenue was down 33.8% on a year-over-year basis. During the same period in the prior year, the business posted $0.21 EPS. Aspen Aerogels has set its FY 2025 guidance at -3.860–3.730 EPS. Equities research analysts expect that Aspen Aerogels, Inc. will post 0.17 EPS for the current fiscal year.

Aspen Aerogels Profile

Aspen Aerogels, Inc designs, develops, manufactures, and sells aerogel insulation products primarily for use in the energy infrastructure and sustainable insulation materials markets in the United States, Asia, Canada, Europe, and Latin America. It operates in two segments, Energy Industrial and Thermal Barrier.